Indication

Cutaneous candidiasis

Cutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species. Read more about Cutaneous candidiasis

364 drugs 131 manufacturers

Advertisement

Drugs that treat it

Common Cutaneous candidiasis therapies.

Showing 289–297 of 364 drugs

KETOCONAZOLE

ANTIFUNGALS-SYSTEMIC·TINEA CRURIS·+6
A-S MEDICATION

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·CUTANEOUS CANDIDIASIS
A-S MEDICATION

NYSTATIN

TOPICAL ANTIFUNGALS·CUTANEOUS CANDIDIASIS
DR.REDDY'S LAB

KETOCONAZOLE

ANTIFUNGALS-SYSTEMIC·TINEA CRURIS·+6
GSMS, INC.

NYSTATIN

TOPICAL ANTIFUNGALS·CUTANEOUS CANDIDIASIS
DIRECT RX
Filter & compare in the drug finder →Opens the drug finder with Cutaneous candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cutaneous candidiasis.

Cutaneous candidiasis is a superficial fungal infection of the skin primarily caused by the opportunistic yeast *Candida albicans*, as well as other non-albicans *Candida* species.

It predominantly affects the integumentary system, flourishing in warm, moist, and occluded intertriginous areas such as the axillae, groin, inframammary folds, and digital web spaces.

Pathophysiologically driven by epidermal barrier compromise, local maceration, or altered host immunity, the condition clinically manifests as pruritic, bright red erythematous patches accompanied by maceration, peripheral scaling, and characteristic satellite pustules or papules.

Personalize your experience

Follow Cutaneous candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it